Clinical and metabolic subtypes of recent-onset adult type 1 diabetes: a prospective cohort study

医学 前瞻性队列研究 队列研究 内科学 梅德林 队列 年轻人 儿科 肿瘤科 回顾性队列研究 文本挖掘
作者
Katsiaryna Prystupa,Andreas Fritsche,Christian Binsch,Stefanie Lanzinger,Łukasz Szczerbiński,Adrian Janucik,Adam Jacek Kretowski,Oana‐Patricia Zaharia,Geronimo Heilmann,Nina Trinks,Maximilian Huttasch,Klaus Straßburger,Gidon Josia Bönhof,Alexander Strom,Rainer Guthoff,Syed M. Ijlal Haider,Alexander Dilthey,Tobias Marschall,Kálmán Bódis,Volker Burkart
出处
期刊:The Lancet Diabetes & Endocrinology [Elsevier BV]
标识
DOI:10.1016/s2213-8587(26)00233-0
摘要

BACKGROUND: Adult-onset type 1 diabetes exhibits substantial heterogeneity. We aimed to investigate whether this variability reflects distinct disease entities or different temporal stages of a shared autoimmune process. METHODS: In this prospective cohort study, we analysed data from adults (aged 18-69 years) in the German Diabetes Study who had clinically diagnosed type 1 diabetes within the preceding 12 months, and from individuals who were positive for glutamic acid decarboxylase antibody (GADA) but had originally been diagnosed with type 2 diabetes. We used unsupervised machine learning based on GADA status, fasting C-peptide, glucose, triglycerides, and HDL cholesterol to characterise clinical and metabolic type 1 diabetes subtypes. The resulting subtypes were compared for aetiological traits (polygenic risk scores for type 1 diabetes and type 2 diabetes, partitioned type 2 diabetes polygenic risk scores, human leukocyte antigen [HLA] profiles, and islet-directed autoantibodies), insulin sensitivity, glucagon-stimulated C-peptide trajectories as a measure of residual β-cell function, and complications during prospective follow-up. Reproducibility was assessed in adults with type 1 diabetes from the German Diabetes Prospective Follow-up Registry (Diabetes-Patienten-Verlaufsdokumentation [DPV]). FINDINGS: Analysed participants in the German Diabetes Study cohort were recruited between June 27, 2005, and Jan 20, 2025 (n=600), and were followed up for a mean of 6·1 (SD 4·7) years. We identified three type 1 diabetes subtypes: two GADA-positive subtypes, and one GADA-negative subtype. A similar clinical and metabolic subtype structure was observed in the DPV cohort, whose participants were recruited between 2000 and 2025 (n=483) and were followed up for a mean of 3·1 (SD 5·0) years. One GADA-positive subtype was characterised by lower BMI, higher insulin sensitivity, and severe β-cell dysfunction (classic type 1 diabetes), whereas the second showed higher BMI, lower insulin sensitivity, and better β-cell function (mixed type 1 diabetes). The two GADA-positive subtypes did not differ in autoimmunity or type 1 diabetes polygenic risk scores, whereas the GADA-negative subtype had lower genetic type 1 diabetes risk, despite no clear subtype-specific differences in HLA risk haplotypes. Longitudinal modelling indicated that the mixed type 1 diabetes group was positioned 6·1 years (95% CI 4·6-7·8) earlier along the β-cell function decline trajectory compared with the classic type 1 diabetes group. The risks of hypoglycaemia (log-rank p=0·0019), retinopathy (mixed type 1 diabetes vs classic type 1 diabetes: adjusted hazard ratio 4·93 [95% CI 1·71-14·24]), and cardiovascular autonomic neuropathy (log-rank p=0·028) differed across the groups. INTERPRETATION: Our results indicate that individuals with combined autoimmunity and lower insulin sensitivity present with clinical diabetes earlier than classic type 1 diabetes along the β-cell decline trajectory, identifying a potential timeframe for disease-modifying interventions in specific type 1 diabetes subtypes. FUNDING: BreakthroughT1D, German Research Foundation (DFG), German Center for Diabetes Research (DZD), Schmutzler Stiftung, German Federal Ministry of Health, Ministry of Culture and Science of the State of North Rhine-Westphalia, and German Federal Ministry of Education and Research. TRANSLATION: For the German translation of the abstract see Supplementary Materials section.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YUAN完成签到,获得积分20
刚刚
刚刚
追逐梦想的打工人完成签到,获得积分10
1秒前
cdc完成签到 ,获得积分10
1秒前
1秒前
淡定的静枫完成签到,获得积分10
1秒前
qian发布了新的文献求助10
1秒前
一米阳光发布了新的文献求助10
1秒前
jzhou65发布了新的文献求助10
2秒前
枫楠完成签到,获得积分10
2秒前
斯文败类的应助被俊秀的火车采纳,获得10
3秒前
3秒前
搜集达人的应助被明芷蝶采纳,获得10
4秒前
4秒前
duduqiang发布了新的文献求助10
4秒前
4秒前
田様的应助被自由井采纳,获得10
5秒前
horse66发布了新的文献求助10
5秒前
董ww发布了新的文献求助10
5秒前
无极微光的应助被阿辉采纳,获得182
6秒前
我是老大的应助被Helium采纳,获得10
6秒前
sunnio完成签到,获得积分10
6秒前
6秒前
7秒前
领导范儿的应助被Jeannie采纳,获得10
7秒前
Doki完成签到,获得积分20
7秒前
激动的元瑶完成签到 ,获得积分10
7秒前
7秒前
甜美折耳根完成签到,获得积分10
7秒前
从容的映之完成签到,获得积分10
8秒前
cjk发布了新的文献求助10
8秒前
文静的笑槐完成签到,获得积分10
9秒前
lee发布了新的文献求助70
9秒前
9秒前
9秒前
9秒前
略略略爱完成签到,获得积分10
9秒前
uiii发布了新的文献求助10
9秒前
10秒前
初景发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160467
求助须知:如何正确求助?哪些是违规求助? 9555463
关于积分的说明 21728123
捐赠科研通 7750270
什么是DOI,文献DOI怎么找? 3427393
关于科研通互助平台的介绍 2552425
邀请新用户注册赠送积分活动 2471741